Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 11.

Batool, M., Berghausen, E. M., Vantler, M., Zierden, M., Baldus, S., Rosenkranz, S. and Ten Freyhaus, H. (2018). Deficiency of the six-transmembrane protein Stamp2 promotes hypoxia-induced pulmonary vascular remodeling and pulmonary hypertension via cross-talk between macrophages and smooth muscle cells. Eur. Heart J., 39. S. 238 - 239. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Berghausen, E. M., Janssen, W., Vantler, M., Ten Freyhaus, H., Baldus, S., Schermuly, R. and Rosenkranz, S. (2014). Pharmacological Inhibition Of The Pi 3-Kinase Isoform P110 alpha Prevents Vascular Remodeling And Experimental Ph. Am. J. Respir. Crit. Care Med., 189. NEW YORK: AMER THORACIC SOC. ISSN 1535-4970

Bokredenghel, S., Mollenhauer, M., Bablok, S., Ruther, T., Proksch, C., Berghausen, E. M., Vantler, M., Rosenkranz, S., Baldus, S., Rudolph, V. and Ten Freyhaus, H. (2018). Stamp2 diminishes structural remodeling and systolic dysfunction in post-ischemic hearts by its anti-inflammatory properties. Eur. Heart J., 39. S. 186 - 187. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Huntgeburth, M., Ten Freyhaus, H., Sunderkamp, C., Baldus, S. and Rudolph, V. (2015). Novel method for determination of mitral regurgitation severity before and after percutaneous edge-to-edge mitral valve repair by contrast echocardiography. Eur. Heart J., 36. S. 174 - 176. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Kramer, T., Orlova, K., Gerhardt, F., Dumitrescu, D., Ten Freyhaus, H., Baldus, S. and Rosenkranz, S. (2017). Therapeutic effects of phosphodiesterase 5 inhibitors in patients with heart failure with preserved ejection fraction (HFpEF) and combined post-and pre-capillary pulmonary hypertension (Cpc-PH). Eur. Heart J., 38. S. 545 - 547. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Kramer, T., Orlova, K., Gerhardt, F., Dumitrescu, D., Ten Freyhaus, H., Baldus, S. and Rosenkranz, S. (2017). Therapeutic potential of phosphodiesterase 5 inhibitors in patients with heart failure with preserved ejection fraction (HFpEF) and combined post- and pre-capillary pulmonary hypertension (Cpc-PH). Eur. J. Heart Fail., 19. S. 531 - 532. HOBOKEN: WILEY. ISSN 1879-0844

Ten Freyhaus, H., Batool, M., Berghausen, E. M., Joseph, C., Zierden, M., Vantler, M., Baldus, S. and Rosenkranz, S. (2017). The six-transmembrane protein Stamp2 protects from pulmonary vascular remodeling and pulmonary hypertension in mice. Eur. Heart J., 38. S. 1340 - 1341. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Ten Freyhaus, H., Batool, M., Berghausen, E. M., Zierden, M., Vantler, M., Baldus, S. and Rosenkranz, S. (2016). The six-transmembrane protein Stamp2 protects from experimental pulmonary hypertension. Eur. Heart J., 37. S. 908 - 909. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Ten Freyhaus, H., Berghausen, E. M., Janssen, W., Leuchs, M., Zierden, M., Vantler, M., Baldus, S., Schermuly, R. T., Tallquist, M. D. and Rosenkranz, S. (2014). Critical role of PDGF-induced PI3 kinase and PLCg signaling in human and experimental pulmonary hypertension. Eur. Heart J., 35. S. 198 - 199. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Ten Freyhaus, H., Dumitrescu, D., Schnorbach, S., Kappert, K., Viethen, T., Hellmich, M., Baldus, S., Hunuzelmann, N. and Rosenkranz, S. (2015). CT-proET1 predicts survival in scleroderma-associated pulmonary hypertension. Eur. Heart J., 36. S. 627 - 628. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

Ten Freyhaus, H., Mollenhauer, M., Bokredenghel, S., Bablok, S., Ruther, T., Proksch, C., Berghausen, E. M., Vantler, M., Rosenkranz, S., Baldus, S. and Rudolph, V. (2017). Deficiency of the six-transmembrane protein Stamp2 promotes structural remodeling and systolic dysfunction in left ventricular myocardial ischemia-reperfusion injury. Eur. Heart J., 38. S. 1138 - 1139. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645

This list was generated on Fri Mar 29 00:37:08 2024 CET.